UnitedHealth Group Incorporated (NYSE:UNH) is Ulland Investment Advisors LLC’s 7th Largest Position

Ulland Investment Advisors LLC lessened its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.8% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 12,332 shares of the healthcare conglomerate’s stock after selling 483 shares during the quarter. UnitedHealth Group makes up approximately 5.3% of Ulland Investment Advisors LLC’s portfolio, making the stock its 7th largest holding. Ulland Investment Advisors LLC’s holdings in UnitedHealth Group were worth $7,210,000 at the end of the most recent quarter.

Several other large investors also recently added to or reduced their stakes in the business. Kathleen S. Wright Associates Inc. acquired a new stake in UnitedHealth Group in the 3rd quarter worth approximately $27,000. Macroview Investment Management LLC lifted its stake in shares of UnitedHealth Group by 671.4% in the second quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock worth $28,000 after buying an additional 47 shares during the last quarter. Delos Wealth Advisors LLC grew its stake in UnitedHealth Group by 757.1% in the 1st quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock valued at $30,000 after buying an additional 53 shares during the last quarter. Bbjs Financial Advisors LLC acquired a new position in UnitedHealth Group during the 2nd quarter worth $31,000. Finally, Global Wealth Strategies & Associates grew its position in shares of UnitedHealth Group by 152.4% in the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock valued at $31,000 after purchasing an additional 32 shares during the last quarter. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Trading Down 6.8 %

Shares of UNH traded down $41.25 during trading hours on Tuesday, reaching $564.15. The stock had a trading volume of 7,272,545 shares, compared to its average volume of 3,930,576. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $608.63. The company has a quick ratio of 0.88, a current ratio of 0.88 and a debt-to-equity ratio of 0.67. The company has a market cap of $520.95 billion, a P/E ratio of 36.47, a P/E/G ratio of 1.66 and a beta of 0.58. The firm has a 50-day moving average of $584.39 and a 200 day moving average of $532.15.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share for the quarter, beating the consensus estimate of $6.66 by $0.14. The company had revenue of $98.86 billion during the quarter, compared to analysts’ expectations of $98.73 billion. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The business’s quarterly revenue was up 6.4% compared to the same quarter last year. During the same quarter in the prior year, the company earned $6.14 earnings per share. On average, sell-side analysts expect that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th were paid a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 1.49%. The ex-dividend date of this dividend was Monday, September 16th. UnitedHealth Group’s payout ratio is 55.70%.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on UNH shares. KeyCorp began coverage on shares of UnitedHealth Group in a research report on Friday. They set an “overweight” rating and a $675.00 price objective for the company. Royal Bank of Canada raised their price objective on UnitedHealth Group from $555.00 to $615.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 17th. StockNews.com cut UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Wednesday, September 25th. Robert W. Baird boosted their price target on shares of UnitedHealth Group from $597.00 to $640.00 and gave the company an “outperform” rating in a report on Wednesday, July 17th. Finally, TD Cowen upped their target price on shares of UnitedHealth Group from $546.00 to $601.00 and gave the company a “buy” rating in a research note on Wednesday, July 17th. Two equities research analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, UnitedHealth Group has an average rating of “Buy” and an average target price of $617.37.

Insider Transactions at UnitedHealth Group

In other news, CAO Thomas E. Roos sold 2,851 shares of the firm’s stock in a transaction dated Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the transaction, the chief accounting officer now owns 29,501 shares in the company, valued at $16,812,029.88. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In related news, EVP Erin Mcsweeney sold 1,500 shares of UnitedHealth Group stock in a transaction dated Thursday, July 18th. The stock was sold at an average price of $579.03, for a total transaction of $868,545.00. Following the completion of the transaction, the executive vice president now owns 7,785 shares in the company, valued at approximately $4,507,748.55. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CAO Thomas E. Roos sold 2,851 shares of the firm’s stock in a transaction that occurred on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the sale, the chief accounting officer now directly owns 29,501 shares of the company’s stock, valued at approximately $16,812,029.88. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 0.33% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.